Ausgabe 8/2018
Special Issue: Dyskinesia in Parkinson’s disease: clinical features and experimental evidence
Inhalt (19 Artikel)
Dyskinesia in Parkinson’s disease: a clinical complication and an open scientific question
Manolo Carta, Etienne Hirsch
Levodopa-induced dyskinesia: clinical features, incidence, and risk factors
Tai N. Tran, Trang N. N. Vo, Karen Frei, Daniel D. Truong
Dyskinesias and levodopa therapy: why wait?
Michele Matarazzo, Alexandra Perez-Soriano, A. Jon Stoessl
Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease
Angelo Antonini, Bianca Nitu
Animal models of l-DOPA-induced dyskinesia: the 6-OHDA-lesioned rat and mouse
Elisabetta Tronci, Veronica Francardo
Pathophysiology of dyskinesia and behavioral disorders in non-human primates: the role of serotonergic fibers
Véronique Sgambato, Léon Tremblay
On the neuronal circuitry mediating l-DOPA-induced dyskinesia
M. Angela Cenci, Henrik Jörntell, Per Petersson
Signal transduction in l-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression
Giada Spigolon, Gilberto Fisone
Dopamine receptors: homomeric and heteromeric complexes in l-DOPA-induced dyskinesia
Oscar Solís, Rosario Moratalla
The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective
Manolo Carta, Anders Björklund
Serotonergic targets for the treatment of l-DOPA-induced dyskinesia
Kathryn Lanza, Christopher Bishop
The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
Gennaro Pagano, Flavia Niccolini, Marios Politis
Glutamatergic mechanisms in l-DOPA-induced dyskinesia and therapeutic implications
Manuela Mellone, Fabrizio Gardoni
Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia
Santiago Perez-Lloret, Olivier Rascol
The striatal cholinergic system in l-dopa-induced dyskinesias
X. A. Perez, T. Bordia, M. Quik
Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities
Barbara Picconi, Elvira De Leonibus, Paolo Calabresi
Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia
Annalisa Pinna, Marcello Serra, Micaela Morelli, Nicola Simola
Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
Augusta Pisanu, Laura Boi, Giovanna Mulas, Saturnino Spiga, Sandro Fenu, Anna R. Carta
Impulse control disorders in Parkinson’s disease
Ana Marques, Franck Durif, Pierre-Olivier Fernagut